1

Exhibit 10.36

March 28, 2000

Dr. Wolfram Weinsheimer
Kuerzlengraben 15A
D-89275 Elchingen, Germany

Dear Wolfram:

         I hope all is well. In preparation for our public offering, we will be
operating as a business development corporation, which has its own legal
requirements. Accordingly, we will no longer be able to compensate regional
representatives with shares of stock in companies who acquire technologies from
us.

         Instead of the current 10% equity commission upon the consummation of
any successful technology transfer (which results from your efforts), we will
now provide you with a $20,000 cash commission upon the successful sale of a
UTEK licensed technology.

         If you agree to this new commission program, please sign below and fax
back to Carole Mason, CFO, by April 12th, 2000.

         I appreciate all of your efforts to-date and look forward to our
continued mutually beneficial relationship.

Very best regards,


/s/  Uwe Reischl


Uwe Reischl, Ph.D., M.D.
President


Cc: Sam Reiber


Agreed to:     /s/  Dr. Wolfram Weinsheimer     Date  00-04-06
          --------------------------------------     -------------